Open AccessCombinatorial treatment with menin and FLT3 inhibitors induces complete remission in AML models with activating FLT3 mutations
Author(s) -
Hongzhi Miao,
Eungi Kim,
Dong Chen,
Trupta Purohit,
Katarzyna Kempińska,
James Ropa,
Szymon Kłossowski,
Winifred Trotman,
Gwenn Danet-Desnoyers,
Tomasz Cierpicki,
Jolanta Grembecka
Publication year - 2020
Publication title -
blood
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.515
H-Index - 465
eISSN - 1528-0020
pISSN - 0006-4971
DOI - 10.1182/blood.2020006575
Subject(s) - complete remission , venetoclax , cancer research , mutation , fms like tyrosine kinase 3 , medicine , azacitidine , leukemia , oncology , biology , genetics , gene , chemotherapy , gene expression , chronic lymphocytic leukemia , dna methylation
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom